Tyrosine Kinase Inhibitors Market to Register Strong Growth at CAGR of 8.20% by 2029

Retrieved on: 2022-05-23 18:03:20

Tags for this article:

Enzymes

Clinical medicine

Branches of biology

Tyrosine kinase receptors

Tyrosine kinase

Philadelphia chromosome

Chronic myelogenous leukemia

Protein kinase inhibitor

Bcr-Abl tyrosine-kinase inhibitor

Proto-oncogene tyrosine-protein kinase Src

Bemcentinib

Click the tags to see associated articles and topics

Tyrosine Kinase Inhibitors Market to Register Strong Growth at CAGR of 8.20% by 2029. View article details on hiswai:

Excerpt

Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Bayer AG Deciphera Pharmaceuticals, Inc. Johnson & Johnson Services, Inc., Ascentage ...

Article found on: www.digitaljournal.com

View Original Article